Open AccessCrohn’s disease with infliximab treatment complicated by rapidly progressing colorectal cancer: A case report
Author(s) -
Lin Xiao,
Limei Sun,
Kang Zhao,
Yisheng Pan
Publication year - 2021
Publication title -
world journal of gastrointestinal oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.924
H-Index - 26
ISSN - 1948-5204
DOI - 10.4251/wjgo.v13.i4.305
Subject(s) - medicine , infliximab , colorectal cancer , inflammatory bowel disease , crohn's disease , disease , oncology , gastroenterology , cancer
Crohn's disease (CD) causes a range of digestive symptoms including recurrent diarrhea, abdominalgia, and flatulence, and severely impacts the quality of life of patients. Infliximab, a monoclonal antibody against tumor necrosis factor alpha, has recently been promoted as a therapeutic treatment for CD, but its safety margins remain uncertain. We report a case of rapidly progressive colorectal cancer that was diagnosed in a patient with CD who had previously been treated with infliximab.